Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified?
In order to address the question of whether biological measurements might identify women with benign breast disease (BBD) at particular risk for breast cancer, analyses were performed on cyst fluids aspirated from patients presenting with palpable breast cysts. Electrolyte profiles showed that cyst fluids may be divided into major subpopulations which differ in terms of histological appearance of cyst lining epithelium, pattern of cyst presentation, and levels of other fluid constituents such as androgen conjugates and epidermal growth factor. Analysis of cyst fluids from 18 patients who subsequently developed breast cancer 1 to 8 years later showed that 12 individuals had group A cysts, three had group B cysts, and three presented with a mixture of the two types. Therefore, although this represents an increased proportion of group A cysts as compared with the total population of cyst fluids studied over the same time period, individuals subsequently developing breast cancer were not confined to one subgroup of cysts. Androgen conjugate and growth factor content also did not predict for subsequent cancer. At the present time, it is therefore concluded that biochemical measurements in cyst fluids cannot accurately identify women likely to develop breast cancer. However, the routine aspiration of cysts does provide the opportunity to monitor the local microenvironment of the breast.
Miller
W R
WR
Imperial Cancer Research Fund, Medical Oncology Unit, Western General Hospital, Edinburgh, Scotland.
Scott
W N
WN
Harris
W H
WH
Wang
D
D
D000728:Androgens / Q000032:analysis; D001943:Breast Neoplasms / Q000209:etiology*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000737:chemistry / Q000145:classification* / Q000150:complications / Q000473:pathology; D006133:Growth Substances / Q000032:analysis; D006801:Humans; D012307:Risk Factors
D000728:Androgens; D006133:Growth Substances